Chandan Healthcare Ltd

Chandan Healthcare Ltd

₹ 166 -0.48%
25 Feb - close price
About

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]

Key Points

Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points

  • Market Cap 406 Cr.
  • Current Price 166
  • High / Low 176 / 159
  • Stock P/E
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 4.23 %
  • ROE -2.99 %
  • Face Value 10.0

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -20.7%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022
66.56 55.95 71.39
60.36 51.00 68.02
Operating Profit 6.20 4.95 3.37
OPM % 9.31% 8.85% 4.72%
0.23 0.08 0.20
Interest 1.78 2.01 2.33
Depreciation 2.31 1.54 1.95
Profit before tax 2.34 1.48 -0.71
Tax % 39.32% 44.59% 0.00%
1.42 0.82 -0.71
EPS in Rs 0.71 0.41 -0.36
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 28%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -187%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022
Equity Capital 20.00 20.00 20.00
Reserves 3.96 4.94 2.61
14.66 13.75 15.38
20.30 17.50 21.51
Total Liabilities 58.92 56.19 59.50
20.32 20.16 0.00
CWIP 0.00 0.00 0.00
Investments 19.93 11.03 14.12
18.67 25.00 45.38
Total Assets 58.92 56.19 59.50

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022
-6.63 10.09
7.45 -9.52
-0.50 -1.06
Net Cash Flow 0.32 -0.48

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022
Debtor Days 53.91 76.07 53.38
Inventory Days 87.92 77.99 40.74
Days Payable 126.35 223.52 495.50
Cash Conversion Cycle 15.47 -69.47 -401.38
Working Capital Days -33.12 33.99 -15.80
ROCE % 9.03% 4.23%

Shareholding Pattern

Numbers in percentages

9 Recently
Feb 2025
49.20%
6.48%
5.35%
38.97%
No. of Shareholders 3,099

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

No data available.

Annual reports

No data available.